Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis
about
Pathophysiology of gene-targeted mouse models for cystic fibrosisSmall changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and diseaseDefective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression.Abnormal secretagogue-induced intracellular free Ca2+ regulation in cystic fibrosis nasal epithelial cellsTLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.Yet another role for the cystic fibrosis transmembrane conductance regulator.Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cellsEnhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.The clinical chemistry of inorganic sulfate.Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosisMucociliary clearance in cystic fibrosis.CFTR!Lung infections. 3. Pseudomonas aeruginosa and other related species.Gene therapy for cystic fibrosis: challenges and future directionsPseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins.Carbohydrate-deficient transferrin (CDT)--a biomarker for long-term alcohol consumption.The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue.CFTR, mucins, and mucus obstruction in cystic fibrosis.The effect of divalent vs. monovalent ions on the swelling of mucin-like polyelectrolyte gels: governing equations and equilibrium analysisMicrobiology of airway disease in patients with cystic fibrosis.Cystic fibrosis. 4. Abnormalities of airway epithelial function and the implications of the discovery of the cystic fibrosis gene.Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patientsA delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.Characterization of a sulfotransferase from human airways responsible for the 3-O-sulfation of terminal galactose in N-acetyllactosamine-containing mucin carbohydrate chains.Characterization of an N-acetylglucosamine-6-O-sulfotransferase from human respiratory mucosa active on mucin carbohydrate chains.Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.Reduced surface toll-like receptor-4 expression and absent interferon-γ-inducible protein-10 induction in cystic fibrosis airway cells.Abnormal fucosylation of-ileal mucus in cystic fibrosis: II. A histochemical study using monoclonal antibodies to fucosyl oligosaccharidesExpression of N-acetylglucosamine 6-O-sulfotransferases (GlcNAc6STs)-1 and -4 in human monocytes: GlcNAc6ST-1 is implicated in the generation of the 6-sulfo N-acetyllactosamine/Lewis x epitope on CD44 and is induced by TNF-alpha.The role of airway mucus in pulmonary toxicology.Clinical aspects of glycoprotein biosynthesis.Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells.Interactions between glycoconjugates from human respiratory airways and Pseudomonas aeruginosa.Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates.Characterization of guinea pig tracheal epithelial cells maintained in biphasic organotypic culture: cellular composition and biochemical analysis of released glycoconjugates.Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.Distinct populations of high-M(r) mucins secreted by different human salivary glands discriminated by density-gradient electrophoresis.
P2860
Q28295602-7FE5E008-2EBE-4369-836A-67E4E3144FAEQ28396109-E45B5337-A43A-4E3D-B5A4-73D8864DF342Q30628431-F92A15A6-7825-415F-A4AF-CBF2836BE29CQ30789722-BD1DFF4E-B491-4233-B5D7-2F0B5AAAC5CCQ31144471-07A6F743-9BF9-4BFE-9E4B-275BF4C0F89DQ33209490-17332EF0-8DFB-4632-A22A-F95C0A534BCFQ33765010-CDAF6D77-C3A9-4BDF-A3D9-EE619A3FA606Q33806101-6E2FD095-FF0E-49BE-990F-F3B682EBB3C3Q33905211-21A530E9-A1A3-4CA0-AE1B-5726902867CFQ34008714-191FDDF2-F0BB-4D83-B275-FD979FE2582AQ34030339-B9745DEF-7EA8-4461-95FB-41BF05628643Q34347531-FE4B9DC5-B64A-4AC4-9FAA-20C8A58A340AQ34581003-9B71E446-A30E-40D9-9E5E-93FEFEA71485Q35334619-127E566B-FA1C-4B75-9A82-24A39164BAE3Q35532283-11BD197B-C085-45E7-879D-005D4D6C5D89Q35767578-C26BA107-610B-44C7-AE0C-0B08A063207AQ35780258-F8E9E919-D512-4A2F-ABF8-F05B51428D79Q35809820-F1C5080E-01EF-4E79-8542-325B4EC9CA41Q35817447-7E6CB7E1-0451-44BB-8837-D723430E709CQ36186528-D936E960-F337-42D4-9085-72EE746ED322Q36564856-F05FF6A6-10A9-4B2C-9634-A1810ED0E09DQ36636914-E30A7BDE-79A8-4B7C-8545-4A632DA85AB3Q36639844-E2C4BF5E-F016-483C-96A2-522BEEAFABADQ36802440-A4F81DAD-9951-4861-9CDE-2E8E184B4335Q37359641-FA386705-64E4-4D13-A3CE-804F20F82BFCQ38153821-664520BF-1F50-4814-B7A0-2FE4B507CFE8Q38289130-ABDE4C98-C40B-4C5D-B177-1A8F77782A06Q38341349-2E076BAF-2268-4250-85DC-1CDA6CE7FB86Q38566057-95B9E5F4-3901-40A9-AB21-CCEB28E01C92Q39529201-7B72DAF0-2FAA-4F99-B1E0-682FA0CBE570Q39657665-328577C2-C790-4CC8-9319-4340E6A66E96Q40454908-E04DFCBC-BD98-4966-B342-A70BC0261CC9Q40632207-36A1B96B-6318-4A32-B8EE-AA738E120C20Q40841843-F1E2BB2E-3C7D-4DEA-95B1-B2069EA9BD7EQ41017727-FFE26C46-FA7B-4A81-BFC5-D566014D1857Q41171871-838AB8A8-FD11-4D6B-8EAA-A4035EBDA91BQ41492766-6036B395-1821-45EA-80E5-F439C33B1B15Q41789847-3592DFEF-26DF-46DF-BA5B-FC33925821EEQ41937730-15D7AC78-E850-4C2E-AAAC-8889896449E6Q42001335-7F02341B-AF51-47DA-8340-60B17B218DA8
P2860
Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Increased sulfation of glycoco ...... patients with cystic fibrosis
@ast
Increased sulfation of glycoco ...... patients with cystic fibrosis
@en
Increased sulfation of glycoco ...... patients with cystic fibrosis
@nl
type
label
Increased sulfation of glycoco ...... patients with cystic fibrosis
@ast
Increased sulfation of glycoco ...... patients with cystic fibrosis
@en
Increased sulfation of glycoco ...... patients with cystic fibrosis
@nl
prefLabel
Increased sulfation of glycoco ...... patients with cystic fibrosis
@ast
Increased sulfation of glycoco ...... patients with cystic fibrosis
@en
Increased sulfation of glycoco ...... patients with cystic fibrosis
@nl
P2093
P2860
P356
P1476
Increased sulfation of glycoco ...... patients with cystic fibrosis
@en
P2093
J R Yankaskas
K Cranfill
R C Boucher
P2860
P356
10.1172/JCI114171
P407
P577
1989-07-01T00:00:00Z